Aer Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D

Aer Therapeutics is a clinical stage biopharmaceutical company developing AER-01 (fexlamose) to treat serious muco-obstructive respiratory diseases such as COPD, asthma, Cystic Fibrosis and bronchiectasis
Address
RaleighNorth Carolina
United States